Report Detail

Request for Sample of this report

Other Global Type 1 Diabetes Medicines Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4589412
    • |
  • 21 May, 2024
    • |
  • Global
    • |
  • 132 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

Type 1 diabetes is a chronic (life-long) autoimmune disease that prevents your pancreas from making insulin. It requires daily management with insulin injections and blood sugar monitoring. Both children and adults can be diagnosed with Type 1 diabetes. Even after a lot of research, type 1 diabetes has no cure. Treatment is directed toward managing the amount of sugar in the blood using insulin, diet and lifestyle to prevent complications.
According to our (Global Info Research) latest study, the global Type 1 Diabetes Medicines market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
According to IDF data, in 2022, around 8.75 million people with type 1 diabete. Among them, 1.52 million patients are under 20. People with type 1 diabetes require daily insulin treatment, regular blood glucose monitoring and a healthy lifestyle to manage their condition effectively.
This report is a detailed and comprehensive analysis for global Type 1 Diabetes Medicines market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Type 1 Diabetes Medicines market size and forecasts, in consumption value ($ Million), 2019-2030
Global Type 1 Diabetes Medicines market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Type 1 Diabetes Medicines market size and forecasts, by Type and by Channel, in consumption value ($ Million), 2019-2030
Global Type 1 Diabetes Medicines market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Type 1 Diabetes Medicines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Type 1 Diabetes Medicines market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, Bayer, Boehringer Ingelheim, Johnson & Johnson, Takeda, Tonghua Dongbao, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Type 1 Diabetes Medicines market is split by Type and by Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Channel. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Type 1 Diabetes Medicines market is split by Type and by Channel. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Channel. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Insulin
Others
Market segment by Channel
Hospital
Retail Pharmacy
Market segment by players, this report covers
Novo Nordisk
Sanofi
Eli Lilly
Merck
AstraZeneca
Bayer
Boehringer Ingelheim
Johnson & Johnson
Takeda
Tonghua Dongbao
United Pharmaceuticals
Ganli Pharmaceutical
Biocon
Wockhardt
Jiangsu Wanbang
Geropharm
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Type 1 Diabetes Medicines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Type 1 Diabetes Medicines, with revenue, gross margin, and global market share of Type 1 Diabetes Medicines from 2019 to 2024.
Chapter 3, the Type 1 Diabetes Medicines competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Channel, with consumption value and growth rate by Type, by Channel, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Type 1 Diabetes Medicines market forecast, by regions, by Type and by Channel, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Type 1 Diabetes Medicines.
Chapter 13, to describe Type 1 Diabetes Medicines research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Type 1 Diabetes Medicines by Type
    • 1.3.1 Overview: Global Type 1 Diabetes Medicines Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Type 1 Diabetes Medicines Consumption Value Market Share by Type in 2023
    • 1.3.3 Insulin
    • 1.3.4 Others
  • 1.4 Global Type 1 Diabetes Medicines Market by Channel
    • 1.4.1 Overview: Global Type 1 Diabetes Medicines Market Size by Channel: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Retail Pharmacy
  • 1.5 Global Type 1 Diabetes Medicines Market Size & Forecast
  • 1.6 Global Type 1 Diabetes Medicines Market Size and Forecast by Region
    • 1.6.1 Global Type 1 Diabetes Medicines Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Type 1 Diabetes Medicines Market Size by Region, (2019-2030)
    • 1.6.3 North America Type 1 Diabetes Medicines Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Type 1 Diabetes Medicines Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Type 1 Diabetes Medicines Market Size and Prospect (2019-2030)
    • 1.6.6 South America Type 1 Diabetes Medicines Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Type 1 Diabetes Medicines Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Novo Nordisk
    • 2.1.1 Novo Nordisk Details
    • 2.1.2 Novo Nordisk Major Business
    • 2.1.3 Novo Nordisk Type 1 Diabetes Medicines Product and Solutions
    • 2.1.4 Novo Nordisk Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Novo Nordisk Recent Developments and Future Plans
  • 2.2 Sanofi
    • 2.2.1 Sanofi Details
    • 2.2.2 Sanofi Major Business
    • 2.2.3 Sanofi Type 1 Diabetes Medicines Product and Solutions
    • 2.2.4 Sanofi Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Sanofi Recent Developments and Future Plans
  • 2.3 Eli Lilly
    • 2.3.1 Eli Lilly Details
    • 2.3.2 Eli Lilly Major Business
    • 2.3.3 Eli Lilly Type 1 Diabetes Medicines Product and Solutions
    • 2.3.4 Eli Lilly Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Eli Lilly Recent Developments and Future Plans
  • 2.4 Merck
    • 2.4.1 Merck Details
    • 2.4.2 Merck Major Business
    • 2.4.3 Merck Type 1 Diabetes Medicines Product and Solutions
    • 2.4.4 Merck Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Merck Recent Developments and Future Plans
  • 2.5 AstraZeneca
    • 2.5.1 AstraZeneca Details
    • 2.5.2 AstraZeneca Major Business
    • 2.5.3 AstraZeneca Type 1 Diabetes Medicines Product and Solutions
    • 2.5.4 AstraZeneca Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 AstraZeneca Recent Developments and Future Plans
  • 2.6 Bayer
    • 2.6.1 Bayer Details
    • 2.6.2 Bayer Major Business
    • 2.6.3 Bayer Type 1 Diabetes Medicines Product and Solutions
    • 2.6.4 Bayer Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Bayer Recent Developments and Future Plans
  • 2.7 Boehringer Ingelheim
    • 2.7.1 Boehringer Ingelheim Details
    • 2.7.2 Boehringer Ingelheim Major Business
    • 2.7.3 Boehringer Ingelheim Type 1 Diabetes Medicines Product and Solutions
    • 2.7.4 Boehringer Ingelheim Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.8 Johnson & Johnson
    • 2.8.1 Johnson & Johnson Details
    • 2.8.2 Johnson & Johnson Major Business
    • 2.8.3 Johnson & Johnson Type 1 Diabetes Medicines Product and Solutions
    • 2.8.4 Johnson & Johnson Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.9 Takeda
    • 2.9.1 Takeda Details
    • 2.9.2 Takeda Major Business
    • 2.9.3 Takeda Type 1 Diabetes Medicines Product and Solutions
    • 2.9.4 Takeda Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Takeda Recent Developments and Future Plans
  • 2.10 Tonghua Dongbao
    • 2.10.1 Tonghua Dongbao Details
    • 2.10.2 Tonghua Dongbao Major Business
    • 2.10.3 Tonghua Dongbao Type 1 Diabetes Medicines Product and Solutions
    • 2.10.4 Tonghua Dongbao Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Tonghua Dongbao Recent Developments and Future Plans
  • 2.11 United Pharmaceuticals
    • 2.11.1 United Pharmaceuticals Details
    • 2.11.2 United Pharmaceuticals Major Business
    • 2.11.3 United Pharmaceuticals Type 1 Diabetes Medicines Product and Solutions
    • 2.11.4 United Pharmaceuticals Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 United Pharmaceuticals Recent Developments and Future Plans
  • 2.12 Ganli Pharmaceutical
    • 2.12.1 Ganli Pharmaceutical Details
    • 2.12.2 Ganli Pharmaceutical Major Business
    • 2.12.3 Ganli Pharmaceutical Type 1 Diabetes Medicines Product and Solutions
    • 2.12.4 Ganli Pharmaceutical Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Ganli Pharmaceutical Recent Developments and Future Plans
  • 2.13 Biocon
    • 2.13.1 Biocon Details
    • 2.13.2 Biocon Major Business
    • 2.13.3 Biocon Type 1 Diabetes Medicines Product and Solutions
    • 2.13.4 Biocon Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Biocon Recent Developments and Future Plans
  • 2.14 Wockhardt
    • 2.14.1 Wockhardt Details
    • 2.14.2 Wockhardt Major Business
    • 2.14.3 Wockhardt Type 1 Diabetes Medicines Product and Solutions
    • 2.14.4 Wockhardt Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Wockhardt Recent Developments and Future Plans
  • 2.15 Jiangsu Wanbang
    • 2.15.1 Jiangsu Wanbang Details
    • 2.15.2 Jiangsu Wanbang Major Business
    • 2.15.3 Jiangsu Wanbang Type 1 Diabetes Medicines Product and Solutions
    • 2.15.4 Jiangsu Wanbang Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Jiangsu Wanbang Recent Developments and Future Plans
  • 2.16 Geropharm
    • 2.16.1 Geropharm Details
    • 2.16.2 Geropharm Major Business
    • 2.16.3 Geropharm Type 1 Diabetes Medicines Product and Solutions
    • 2.16.4 Geropharm Type 1 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Geropharm Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Type 1 Diabetes Medicines Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Type 1 Diabetes Medicines by Company Revenue
    • 3.2.2 Top 3 Type 1 Diabetes Medicines Players Market Share in 2023
    • 3.2.3 Top 6 Type 1 Diabetes Medicines Players Market Share in 2023
  • 3.3 Type 1 Diabetes Medicines Market: Overall Company Footprint Analysis
    • 3.3.1 Type 1 Diabetes Medicines Market: Region Footprint
    • 3.3.2 Type 1 Diabetes Medicines Market: Company Product Type Footprint
    • 3.3.3 Type 1 Diabetes Medicines Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Type 1 Diabetes Medicines Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Type 1 Diabetes Medicines Market Forecast by Type (2025-2030)

5 Market Size Segment by Channel

  • 5.1 Global Type 1 Diabetes Medicines Consumption Value Market Share by Channel (2019-2024)
  • 5.2 Global Type 1 Diabetes Medicines Market Forecast by Channel (2025-2030)

6 North America

  • 6.1 North America Type 1 Diabetes Medicines Consumption Value by Type (2019-2030)
  • 6.2 North America Type 1 Diabetes Medicines Market Size by Channel (2019-2030)
  • 6.3 North America Type 1 Diabetes Medicines Market Size by Country
    • 6.3.1 North America Type 1 Diabetes Medicines Consumption Value by Country (2019-2030)
    • 6.3.2 United States Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Type 1 Diabetes Medicines Consumption Value by Type (2019-2030)
  • 7.2 Europe Type 1 Diabetes Medicines Consumption Value by Channel (2019-2030)
  • 7.3 Europe Type 1 Diabetes Medicines Market Size by Country
    • 7.3.1 Europe Type 1 Diabetes Medicines Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)
    • 7.3.3 France Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Type 1 Diabetes Medicines Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Type 1 Diabetes Medicines Consumption Value by Channel (2019-2030)
  • 8.3 Asia-Pacific Type 1 Diabetes Medicines Market Size by Region
    • 8.3.1 Asia-Pacific Type 1 Diabetes Medicines Consumption Value by Region (2019-2030)
    • 8.3.2 China Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)
    • 8.3.5 India Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Type 1 Diabetes Medicines Consumption Value by Type (2019-2030)
  • 9.2 South America Type 1 Diabetes Medicines Consumption Value by Channel (2019-2030)
  • 9.3 South America Type 1 Diabetes Medicines Market Size by Country
    • 9.3.1 South America Type 1 Diabetes Medicines Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Type 1 Diabetes Medicines Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Type 1 Diabetes Medicines Consumption Value by Channel (2019-2030)
  • 10.3 Middle East & Africa Type 1 Diabetes Medicines Market Size by Country
    • 10.3.1 Middle East & Africa Type 1 Diabetes Medicines Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Type 1 Diabetes Medicines Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Type 1 Diabetes Medicines Market Drivers
  • 11.2 Type 1 Diabetes Medicines Market Restraints
  • 11.3 Type 1 Diabetes Medicines Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Type 1 Diabetes Medicines Industry Chain
  • 12.2 Type 1 Diabetes Medicines Upstream Analysis
  • 12.3 Type 1 Diabetes Medicines Midstream Analysis
  • 12.4 Type 1 Diabetes Medicines Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Type 1 Diabetes Medicines. Industry analysis & Market Report on Type 1 Diabetes Medicines is a syndicated market report, published as Global Type 1 Diabetes Medicines Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Type 1 Diabetes Medicines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,703.96
    		4,055.94
    		5,407.92
    		3,208.56
    		4,812.84
    		6,417.12
    		534,006.00
    		801,009.00
    		1,068,012.00
    		291,484.80
    		437,227.20
    		582,969.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo